Skip to main content

海尔施 — Investor Relations & Filings

Ticker · 601206 Shanghai Stock Exchange Human health and social work activities
Filings indexed 6 across all filing types
Latest filing 2016-08-16 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 601206

About 海尔施

Ningbo Haershi Pharmaceutical Co., Ltd. specializes in the research, development, and distribution of in vitro diagnostic products and pharmaceutical supplies. The organization provides a broad spectrum of diagnostic reagents, laboratory instrumentation, and clinical testing services. It serves as a strategic partner for global medical technology brands, facilitating the integration of advanced diagnostic solutions into clinical workflows. The company’s core activities include the supply of biochemical, immunological, and molecular diagnostic tools designed to support healthcare providers in accurate disease detection and monitoring. Through its comprehensive logistics and technical service network, the entity ensures the reliable delivery and maintenance of critical medical equipment and consumables for hospitals and laboratories.

Recent filings

Filing Released Lang Actions
首次公开发行A股暂缓发行的公告
Regulatory Filings
2016-08-16 Chinese
首次公开发行股票网上路演公告
Regulatory Filings
2016-08-15 Chinese
首次公开发行股票招股意向书附录
Regulatory Filings
2016-08-09 Chinese
首次公开发行股票招股意向书摘要
Regulatory Filings
2016-08-09 Chinese
首次公开发行股票招股意向书
Regulatory Filings
2016-08-09 Chinese
首次公开发行股票发行安排及初步询价公告
Regulatory Filings
2016-08-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.